The Medicines (MDCO)
35.50
+0.10 +0.28%
NASDAQ
Aug 18, 20:00
Delayed 2m
USD
View All Key Stats
MDCO Key Stats
| Income Statement | |
| Revenue (TTM) | 105.76M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -9.95 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -709.05M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 13.13% |
| Profit Margin (Quarterly) | -2.12K% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 0.00 |
| Price and Valuation | |
| Market Cap | 2.579B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 23.81 |
| PE Ratio (TTM) | -- |
| Price to Book Value | 18.04 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | 4.450 |
| Free Cash Flow (Quarterly) | -58.86M |
| Return on Equity (TTM) | -122.2% |
View All MDCO News
MDCO News
-
WireHeadlineTime (ET)
-
Yahoo08/16 14:25
-
Yahoo08/16 08:05
-
Yahoo08/15 08:06
-
Yahoo08/12 08:06
-
Yahoo08/11 08:07
-
Yahoo08/10 16:31
-
Yahoo08/10 16:10
-
Yahoo08/10 08:06
-
Yahoo08/09 22:59
-
Yahoo08/09 08:06
View All Events
MDCO Events
| Date | Type | Description |
|---|---|---|
| 08/09/2017 08:30 EDT | Misc | The Medicines Co Second Quarter Earnings Conference Call in 2017 |
| 08/09/2017 | Earnings | The Medicines Co Second Quarter Earnings in 2017 Release |
| 05/25/2017 | Misc | The Medicines Co Annual General Meeting in 2016 |
| 04/26/2017 08:30 EDT | Misc | The Medicines Co First Quarter Earnings Conference Call in 2017 |
| 04/26/2017 | Earnings | The Medicines Co First Quarter Earnings in 2017 Release |
| 02/28/2017 08:30 EST | Misc | The Medicines Co Fourth Quarter Earnings Conference Call in 2016 |
| 02/28/2017 | Earnings | The Medicines Co Fourth Quarter Earnings in 2016 Release |
| 10/26/2016 08:30 EDT | Misc | The Medicines Co Third Quarter Earnings Results in 2016 |
| 10/26/2016 | Earnings | The Medicines Co Third Quarter Earnings Results in 2016 Release |
MDCO Fundamentals
Income Statement View Statement
MDCO Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
MDCO One Page Reports
- One Page Report Download
MDCO Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Target Price | |
| Price | 35.50 |
| Price Target | Upgrade |
Edit
Profile
- URL: http://www.themedicinescompany.com
- Investor Relations URL: http://ir.themedicinescompany.com/phoenix.zhtml?c=122204&p=irol-irhome
- HQ State/Province: New Jersey
- Sector: Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Next Earnings Release: N/A
- Last Earnings Release: Aug. 09, 2017
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: The Medicines Co is a pharmaceutical company. It provides transformational solutions to address the most pressing healthcare needs facing patients, physicians and providers. The company’s products are Angiomax, Ionsys, Minocin for injection and Orbactiv.
MDCO Comparables
EditMDCO Excel Add-In Codes
- Name: =YCI("MDCO","name")
- Description: =YCI("MDCO","description")
- Sector: =YCI("MDCO","sector")
- Industry: =YCI("MDCO","industry")
- Est. Current Fiscal Year End: =YCI("MDCO","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other MDCO Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- MDCO Tweets Stocktwits
Advertisement
